Zenex Animal Health India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Zenex Animal Health India Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $146.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Zenex Animal Health India Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $146.4K Trade | TransData Nexus

Zenex Animal Health India Private Limited

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $146.4K Total Trade · DGFT Verified

Zenex Animal Health India Private Limited is an Indian pharmaceutical exporter with a total trade value of $146.4K across 3 products in 2 therapeutic categories. Based on 25 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Praziquantel ($71.4K), Pyrantel ($40.8K), Streptomycin ($34.1K).

Zenex Animal Health India Private Limited — Export Portfolio & Destination Treemap

Zenex Animal Health India Private Limited pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Zenex Animal Health India Private Limited? — Company Overview & Market Position

Zenex Animal Health India Private Limited, incorporated on March 9, 2021, is a private company headquartered in Ahmedabad, Gujarat, India. The company is registered with the Corporate Identification Number (CIN) U24299GJ2021PTC120998. As of March 2026, Zenex has an authorized share capital of ₹3,000 crore and a paid-up capital of ₹2,513.10 crore. The company specializes in the manufacture of animal health products, focusing on both allopathic and herbal formulations for livestock, poultry, and companion animals.

In 2023, Zenex reported net sales of ₹7,490.62 million and a total income of ₹7,537.94 million. The company's EBITDA stood at ₹1,782.32 million, with a margin of 23.64%, and a profit after tax (PAT) of ₹193.06 million, reflecting a PAT margin of 2.56%. As of April 9, 2024, Zenex employed 831 individuals, indicating a growing workforce in line with its expanding operations.

What Does Zenex Animal Health India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Praziquantel$71.4K 2

Product Portfolio — Top 3 by Export Value

Zenex Animal Health India Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Praziquantel	Antimalarial & Antiparasitic	$71.4K	14	2.4%	9
2	Pyrantel	Antimalarial & Antiparasitic	$40.8K	8	1.2%	9
3	Streptomycin	Antibiotics	$34.1K	3	5.9%	6

Zenex Animal Health India Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $146.4K. The top category is Antimalarial & Antiparasitic (76.7% of portfolio), followed by Antibiotics (23.3%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Zenex Animal Health India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Zenex operates two state-of-the-art manufacturing facilities in India:

1. Haridwar, Uttarakhand: This plant specializes in pharmaceutical formulations, including injectables, oral liquids, powders, tablets, and boluses. It holds WHO-GMP certification and international regulatory approvals, ensuring high-quality production standards.

2. Baddi, Himachal Pradesh: Focusing on herbal feed supplements and Ayurvedic veterinary products, this facility caters to the growing demand for natural solutions in animal healthcare. It is ISO 9001-2015 certified, with a DSIR-approved R&D facility and an AYUSH-certified Quality Control Lab, underscoring its commitment to quality and innovation.

3Key Leadership

Zenex is led by a team of seasoned professionals:

Renuka Ramnath: Chairperson of Zenex Animal Health India Pvt Ltd, Renuka is also the Founder, Managing Director, and CEO of Multiples Alternate Asset Management Private Limited. With over 35 years in financial services, she has deep experience in private equity, investment banking, and structured finance.

Dr. Arun Atrey: Managing Director and CEO of Zenex, Dr. Atrey has four decades of experience in the animal health industry. He previously served as Managing Director of Zydus Animal Health and has been instrumental in introducing numerous groundbreaking veterinary products to the Indian market.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Zenex Animal Health India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Zenex has made significant strides in obtaining regulatory approvals for its products in various international markets:

United States: Zenex has pursued FDA facility registrations and is in the process of filing Abbreviated New Drug Applications (ANDAs) for its product portfolio. The company is also preparing Drug Master File (DMF) submissions to support its regulatory filings.

European Union: Zenex is working towards obtaining European Medicines Agency (EMA) approvals for its key products, aligning with EU Good Manufacturing Practice (GMP) standards to facilitate market entry.

United Kingdom: The company is in the process of registering its products with the Medicines and Healthcare products Regulatory Agency (MHRA), aiming to meet UK-specific regulatory requirements.

Australia: Zenex is preparing to submit its product dossiers to the Therapeutic Goods Administration (TGA), ensuring compliance with Australian regulatory standards.

Zenex Animal Health India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Zenex is actively engaging with the U.S. Food and Drug Administration (FDA) to establish a presence in the U.S. market:

FDA Facility Registrations: The company has initiated the registration of its manufacturing facilities with the FDA, ensuring compliance with U.S. regulatory standards.

Approved ANDAs: Zenex is in the process of filing ANDAs for its key products, aiming to secure approval for marketing in the U.S.

DMF Filings: The company is preparing DMF submissions to support its ANDA filings, providing detailed information on the manufacturing process and quality control measures.

Inspection History: Zenex's manufacturing facilities are subject to FDA inspections to verify compliance with Current Good Manufacturing Practice (CGMP) regulations.

2WHO & EU GMP

Zenex Animal Health India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Zenex operates in a competitive environment, with several key players in the animal health sector:

Top Competitors: Major competitors include Zoetis India, Elanco Animal Health, and Boehringer Ingelheim India, all of which offer a range of veterinary pharmaceutical products.

Market Share Comparison: While specific market share data is not publicly available, Zenex's focus on both allopathic and herbal formulations positions it uniquely in the market.

Head-to-Head Analysis: Zenex differentiates itself through its dual approach of integrating modern veterinary medicine with Ayurvedic practices, catering to a diverse customer base seeking natural and conventional solutions.

2Key Differentiators

Zenex's unique strengths include:

Frequently Asked Questions — Zenex Animal Health India Private Limited

How many pharmaceutical products does Zenex Animal Health India Private Limited export from India?

Zenex Animal Health India Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Praziquantel ($71.4K), Pyrantel ($40.8K), Streptomycin ($34.1K). Total export value is $146.4K.

What is Zenex Animal Health India Private Limited's total pharmaceutical export value?

Zenex Animal Health India Private Limited's total pharmaceutical export value is $146.4K, based on 25 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Zenex Animal Health India Private Limited cover?

Zenex Animal Health India Private Limited exports across 2 therapeutic categories. The largest are Antimalarial & Antiparasitic (76.7%, 2 products), Antibiotics (23.3%, 1 products).

Get Full Zenex Animal Health India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.